Gene overview
| Strategies/Algorithm: | overlap | Ensembl ID: | |
| Gene: | LOC100505921 | Gene type: | |
| Strand: | External links: |
|
|
| Genomic region: | :- | Genome Browser: |   |
Super-enhancer search result of gene-based
| SE ID | SE Region | Sample ID | Tissue type | Biosample name | SE rank | Element | Common SNP | eQTL | Risk SNP | TFBS | CRISPR Cas9 | Gene |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SE_02_122400038 | chr7:7901876-8134747 |
Sample_02_1224 | Bone marrow | normal plasma cell | 38 | 122 | 7219 | 402 | 25 | 652 | 1131 | ICA1,GLCCI1,LOC100505921 |
| SE_02_107500037 | chr7:7940362-7990438 |
Sample_02_1075 | Lymphoma | BC-3 | 37 | 14 | 1488 | 102 | 4 | 213 | 378 | GLCCI1,LOC100505921 |
| SE_02_107400079 | chr7:7941569-7978003 |
Sample_02_1074 | Lymphoma | BC-1 | 79 | 9 | 1100 | 74 | 3 | 192 | 378 | GLCCI1,LOC100505921 |
| SE_02_122700276 | chr7:7942983-7986871 |
Sample_02_1227 | Bone marrow | U266 | 276 | 11 | 1290 | 85 | 4 | 203 | 378 | GLCCI1,LOC100505921 |
| SE_02_122000043 | chr7:7942987-7974679 |
Sample_02_1220 | Bone marrow | JJN3 | 43 | 8 | 932 | 63 | 3 | 186 | 378 | GLCCI1,LOC100505921 |
| SE_02_151200241 | chr7:7955066-7990248 |
Sample_02_1512 | Lung | Purified AT2 cells | 241 | 5 | 1064 | 67 | 3 | 165 | 378 | GLCCI1,LOC100505921 |
| SE_02_130300549 | chr7:7962456-8003275 |
Sample_02_1303 | Lymphoma | RL_tazemetostat | 549 | 14 | 1214 | 68 | 4 | 152 | 378 | GLCCI1,LOC100505921 |
| SE_02_123500663 | chr7:7963482-7975018 |
Sample_02_1235 | Brain | Neuroblastoma PDX tumour cells | 663 | 8 | 324 | 22 | 2 | 123 | 378 | GLCCI1,LOC100505921 |
| SE_02_150000445 | chr7:7964094-7975562 |
Sample_02_1500 | Brain | KELLY_untreat | 445 | 4 | 322 | 21 | 2 | 123 | 378 | GLCCI1,LOC100505921 |
| SE_02_130400823 | chr7:7964137-8003153 |
Sample_02_1304 | Lymphoma | RL_lenalidomide_tazemetostat | 823 | 15 | 1154 | 66 | 4 | 151 | 378 | GLCCI1,LOC100505921 |
| SE_02_139100511 | chr7:7964477-7997422 |
Sample_02_1391 | Peripheral blood | FE-PD_ALK- | 511 | 6 | 962 | 52 | 4 | 149 | 378 | GLCCI1,LOC100505921 |
| SE_02_138801134 | chr7:7965740-7980523 |
Sample_02_1388 | Peripheral blood | JB6_ALK+ | 1134 | 9 | 417 | 27 | 2 | 118 | 378 | GLCCI1,LOC100505921 |
| SE_02_075001051 | chr7:7967335-7972753 |
Sample_02_0750 | Lymphoma | Rec-1_GSI | 1051 | 1 | 138 | 7 | 2 | 100 | 378 | GLCCI1,LOC100505921 |
| SE_02_085700708 | chr7:7967753-8018761 |
Sample_02_0857 | Glioblastoma | Glioblastoma neurosphere cell_HF-3035 | 708 | 15 | 1546 | 81 | 5 | 161 | 418 | GLCCI1,LOC100505921 |
| SE_02_085400511 | chr7:7968141-7971253 |
Sample_02_0854 | Glioblastoma | Glioblastoma neurosphere cell_HF-2354 | 511 | 1 | 78 | 2 | 1 | 66 | 378 | GLCCI1,LOC100505921 |
| SE_02_096800359 | chr7:7968156-7972385 |
Sample_02_0968 | Brain | H3.3K27M_pcGBM2p18_cells | 359 | 1 | 103 | 2 | 1 | 92 | 378 | GLCCI1,LOC100505921 |
| SE_02_096200598 | chr7:7968168-7974293 |
Sample_02_0962 | Brain | H3.3K27M_Tumor-derived cell-line_DIPGXIIIp11_cells | 598 | 2 | 160 | 7 | 1 | 103 | 378 | GLCCI1,LOC100505921 |
| SE_02_118900444 | chr7:7968201-7974464 |
Sample_02_1189 | Brain | GBM22 | 444 | 3 | 161 | 7 | 1 | 103 | 378 | GLCCI1,LOC100505921 |
| SE_02_119700806 | chr7:7968229-7972467 |
Sample_02_1197 | Brain | GBM33 | 806 | 1 | 102 | 2 | 1 | 92 | 378 | GLCCI1,LOC100505921 |
| SE_02_117900605 | chr7:7968311-7973561 |
Sample_02_1179 | Brain | GBM08 | 605 | 2 | 127 | 4 | 0 | 103 | 378 | GLCCI1,LOC100505921 |
| SE_02_095800536 | chr7:7968660-7976153 |
Sample_02_0958 | Brain | H3.3K27M_Tumor_BT245-X0-2-Rx_xenograft | 536 | 2 | 203 | 9 | 0 | 104 | 357 | GLCCI1,LOC100505921 |
| SE_02_098200490 | chr7:7968686-7972306 |
Sample_02_0982 | Brain | H3.3K27M-KO_BT245-C2P3 | 490 | 2 | 86 | 2 | 0 | 88 | 351 | GLCCI1,LOC100505921 |
| SE_02_096900850 | chr7:7968740-7972602 |
Sample_02_0969 | Brain | H3.3K27M_PL637 | 850 | 1 | 93 | 3 | 0 | 87 | 339 | GLCCI1,LOC100505921 |
Genomic distribution of SEs associated with LOC100505921